PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel darbepoetin alfa in primary breast cancer--results at the time of surgery

✍ Scribed by Untch, M.; Fasching, P. A.; Konecny, G. E.; von Koch, F.; Conrad, U.; Fett, W.; Kurzeder, C.; Luck, H.- J.; Stickeler, E.; Urbaczyk, H.; Liedtke, B.; Salat, C.; Harbeck, N.; Muller, V.; Schmidt, M.; Hasmuller, S.; Lenhard, M.; Schuster, T.; Nekljudova, V.; Lebeau, A.; Loibl, S.; von Minckwitz, G.

• Book ID: 125845153
• Publisher: Oxford University Press
• Year: 2011
• Tongue: English
• Weight: 234 KB
• Volume: 22
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdq709